Summit Investment Advisors »

Tvardi Therapeutics shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Tvardi Therapeutics (TVRD) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Tvardi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tvardi Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tvardi Therapeutics by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $14k 349 38.97
2025-06-30 $8.1k 349 23.33